| scholarly article | Q13442814 |
| P2093 | author name string | William S Lane | |
| John Rush | |||
| Gavin MacBeath | |||
| Bogdan A Budnik | |||
| Alexis Kaushansky | |||
| Andrew Gordus | |||
| P2860 | cites work | A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis | Q22253346 |
| A quantitative protein interaction network for the ErbB receptors using protein microarrays | Q24293746 | ||
| Acetylation-dependent signal transduction for type I interferon receptor | Q24296831 | ||
| The role of STATs in apoptosis | Q24301148 | ||
| Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3 | Q24309266 | ||
| The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone | Q24313108 | ||
| HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers | Q24336345 | ||
| Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients | Q24645597 | ||
| Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling | Q24794988 | ||
| Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase | Q27729401 | ||
| Structure and ligand recognition of the phosphotyrosine binding domain of Shc | Q27732196 | ||
| Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain | Q27732609 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| SH2 domains recognize specific phosphopeptide sequences | Q27860748 | ||
| Untangling the ErbB signalling network | Q27860884 | ||
| ErbB-4: mechanism of action and biology | Q28185260 | ||
| gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase | Q28202328 | ||
| Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry | Q28211506 | ||
| Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas | Q28287906 | ||
| The involvement of ErbB4 with schizophrenia: association and expression studies | Q28290653 | ||
| Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions | Q28609149 | ||
| The structural basis for 14-3-3:phosphopeptide binding specificity | Q29547190 | ||
| Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav | Q29615971 | ||
| The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients* | Q33188817 | ||
| A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. | Q33610352 | ||
| ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. | Q34153957 | ||
| An alternative to SH2 domains for binding tyrosine-phosphorylated proteins | Q34292972 | ||
| Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor | Q34381905 | ||
| SH2 and PTB domains in tyrosine kinase signaling | Q35178872 | ||
| STAT proteins: From normal control of cellular events to tumorigenesis | Q35540165 | ||
| STAT-1: a novel regulator of apoptosis | Q35641356 | ||
| Signal transduction and oncogenesis by ErbB/HER receptors | Q35669114 | ||
| The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients | Q36614287 | ||
| STAT1 as a key modulator of cell death | Q36644901 | ||
| JAK-STAT signaling: from interferons to cytokines | Q36821751 | ||
| The epidermal growth factor family has a dual role in deciding the fate of cancer cells. | Q40209050 | ||
| Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells | Q40772032 | ||
| The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. | Q40808240 | ||
| Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein | Q42159151 | ||
| Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. | Q44314802 | ||
| Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast | Q46402523 | ||
| Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia | Q46775363 | ||
| STATs as activators of apoptosis | Q47721568 | ||
| Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. | Q52183100 | ||
| Circumventing the problems caused by protein diversity in microarrays: implications for protein interaction networks. | Q53011764 | ||
| SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides | Q72332095 | ||
| Binding specificities and affinities of egf domains for ErbB receptors | Q77360929 | ||
| P433 | issue | 8 | |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 808-817 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Chemistry and Biology | Q15758410 |
| P1476 | title | System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties | |
| P478 | volume | 15 |
| Q34511038 | AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity |
| Q37598176 | Applications of protein biochips in biomedical and biotechnological research |
| Q50298005 | Binding of PI3K to p-ERBB2:p-ERBB4 CYT-1 heterodimers |
| Q50298043 | Binding of p85 subunit of PI3K (PIK3R1) to p-ERBB4cyt1 homodimers |
| Q35026889 | Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase. |
| Q92352874 | Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases |
| Q34413697 | Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors |
| Q42265191 | Crosstalk and competition in signaling networks |
| Q90252710 | Deep mutational analysis reveals functional trade-offs in the sequences of EGFR autophosphorylation sites |
| Q41682816 | Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation |
| Q38931276 | Discovering Protein-Protein Interactions Using Nucleic Acid Programmable Protein Arrays. |
| Q36067899 | ERBB4 is over-expressed in human colon cancer and enhances cellular transformation |
| Q47974787 | ErbB Receptors and Cancer |
| Q37734240 | ErbB receptors and their growth factor ligands in pediatric intestinal inflammation |
| Q83601013 | ErbB4 knockdown in serotonergic neurons in the dorsal raphe induces anxiety-like behaviors |
| Q93370017 | ErbB4 point mutation in CU3 inbred rats affects gonadotropin-releasing-hormone neuronal function via compromised neuregulin-stimulated prostaglandin E2 release from astrocytes |
| Q39687374 | ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells |
| Q37149729 | Functional selectivity of EGF family peptide growth factors: implications for cancer |
| Q33747967 | Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system |
| Q26859524 | Identification of Posttranslational Modification-Dependent Protein Interactions Using Yeast Surface Displayed Human Proteome Libraries |
| Q33706791 | Interactive proteomics research technologies: recent applications and advances |
| Q38010411 | Interactome mapping for analysis of complex phenotypes: insights from benchmarking binary interaction assays |
| Q57105786 | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer |
| Q30458926 | Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy |
| Q37722550 | Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis. |
| Q36408020 | Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo |
| Q36804007 | Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling |
| Q36427519 | Phosphotyrosine recognition domains: the typical, the atypical and the versatile |
| Q28284451 | Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected |
| Q35109872 | Protein microarrays: novel developments and applications |
| Q36959749 | Quantifying oncogenic phosphotyrosine signaling networks through systems biology |
| Q34895651 | Quantifying protein-protein interactions in high throughput using protein domain microarrays |
| Q37330722 | Quantitative modeling perspectives on the ErbB system of cell regulatory processes |
| Q36010566 | Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors |
| Q50298039 | SHC1 binds P-ERBB4 isoform dimers |
| Q50297990 | SHC1 binds phosphorylated ERBB2 heterodimers |
| Q45318103 | Signaling by ERBB4 |
| Q27682496 | Superbinder SH2 domains act as antagonists of cell signaling |
| Q35159615 | TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival |
| Q39551398 | Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling |
| Q36468741 | The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis. |
| Q37650953 | The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist. |
| Q34308157 | The application of modular protein domains in proteomics |
| Q50297989 | Trans-autophosphorylation of ERBB2 heterodimers |
| Q50298036 | Trans-autophosphorylation of ERBB4 homodimers |
| Q26801529 | Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association |
| Q27323917 | Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements |
| Q92153694 | Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase |
Search more.